Literature DB >> 10429598

Acetabular revision with allograft bone. 103 revisions with 3 reconstruction alternatives, followed for 0.3-13 years.

P Böhm1, S Banzhaf.   

Abstract

We reviewed 103 consecutive acetabular revisions in 92 patients, for whom allograft bone and 1 of 3 alternative acetabular components had been used: Harris-Galante cup (HGC, 38 hips), Müller acetabular roof reinforcement ring (ARR, 39 hips), or Burch-Schneider antiprotrusio reinforcement cage (APC, 26 hips). The mean follow-up was 4.5 (0.3-13) years. 7 HGCs, 1 ARR, and 1 APC required revision because of aseptic loosening. Using the endpoint revision because of such loosening, the HGC gave 73% survival after 8 years, the ARR 89% after 13 years, and the APC 94% after 11 years. Using a worst-case criterion, survival was 69% for the HGC after 8 years, 84% for the ARR after 13 years, and 83% for the APC after 11 years. Radiographic incorporation of the allograft, no resorption of the allograft, use of a bulk allograft, male gender, and implantation of a reinforcement device were associated with a lower mechanical failure rate. Good durability of allograft bone in reconstructions of bone deficiencies in acetabular revision surgery can be expected when the implant can bridge the temporary period of mechanical weakness of the allograft. Therefore, in severe acetabular deficiencies, reinforcement devices with sufficiently stable fixation in the host bone should be preferred.

Entities:  

Mesh:

Year:  1999        PMID: 10429598     DOI: 10.3109/17453679908997800

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  16 in total

1.  Structural allograft and primary press-fit cup for severe acetabular deficiency. A minimum 6-year follow-up study.

Authors:  F Traina; F Giardina; M De Clerico; A Toni
Journal:  Int Orthop       Date:  2005-04-05       Impact factor: 3.075

2.  Acetabular cage survival and analysis of factors related to failure.

Authors:  Jonathan N Sembrano; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2008-02-26       Impact factor: 4.176

3.  Late fracture of a Burch-Schneider acetabular cage: rare occurrence following polyethylene cup wear.

Authors:  Dario Regis; Andrea Sandri; Alessandra Rizzo; Pietro Bartolozzi
Journal:  BMJ Case Rep       Date:  2009-03-26

4.  [Exchange of acetabular cups with severe bone defects using antiprotrusion cages].

Authors:  Bernd Fink; Alexandra Grossmann; Pavel Sebena
Journal:  Oper Orthop Traumatol       Date:  2010-07       Impact factor: 1.154

5.  Outcome of cages in revision arthroplasty of the acetabulum: a systematic review.

Authors:  Alessandro Aprato; Matteo Olivero; Luigi Branca Vergano; Alessandro Massè
Journal:  Acta Biomed       Date:  2019-01-10

Review 6.  Clinical evaluation and surgical options in acetabular reconstruction: A literature review.

Authors:  Asim Qamar Ahmad; Ran Schwarzkopf
Journal:  J Orthop       Date:  2015-11-02

7.  Acetabular defect reconstruction in revision hip arthroplasty with a modular revision system and biological defect augmentation.

Authors:  Jan Schmolders; Max J Friedrich; Robert D Michel; Thomas M Randau; Matthias D Wimmer; Andreas C Strauss; Hendrik Kohlhof; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2014-10-04       Impact factor: 3.075

8.  Acetabular reconstruction using a free fibular autograft in total hip arthroplasty revisions.

Authors:  Thibaut Noailles; Chiaki Tanaka; Francois Lintz; Sylvie Collon; Kevin Bargoin; Francois Gouin
Journal:  Int Orthop       Date:  2014-07-20       Impact factor: 3.075

9.  [Acetabular reinforcement rings in revision total hip arthroplasty: midterm results in 298 cases].

Authors:  U J Schlegel; R G Bitsch; M Pritsch; P R Aldinger; H Mau; S J Breusch
Journal:  Orthopade       Date:  2008-09       Impact factor: 1.087

10.  The Burch-Schneider antiprotrusio cage: medium follow-up results.

Authors:  J Lamo-Espinosa; J Duart Clemente; P Díaz-Rada; J Pons-Villanueva; J R Valentí-Nín
Journal:  Musculoskelet Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.